43 related articles for article (PubMed ID: 9227225)
1. MRI of breast cancer: influence of chemotherapy on sensitivity.
Rieber A; Zeitler H; Rosenthal H; Görich J; Kreienberg R; Brambs HJ; Tomczak R
Br J Radiol; 1997 May; 70(833):452-8. PubMed ID: 9227225
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Data-Driven Compressed Sensing Reconstruction on Quantitative Pharmacokinetic Analysis in Breast DCE MRI.
Wang PN; Velikina JV; Bancroft LCH; Samsonov AA; Kelcz F; Strigel RM; Holmes JH
Tomography; 2022 Jun; 8(3):1552-1569. PubMed ID: 35736876
[TBL] [Abstract][Full Text] [Related]
3. Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.
Loo CE; Rigter LS; Pengel KE; Wesseling J; Rodenhuis S; Peeters MJ; Sikorska K; Gilhuijs KG
Breast Cancer Res; 2016 Aug; 18(1):82. PubMed ID: 27495815
[TBL] [Abstract][Full Text] [Related]
4. Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response.
Ashraf A; Gaonkar B; Mies C; DeMichele A; Rosen M; Davatzikos C; Kontos D
Transl Oncol; 2015 Jun; 8(3):154-62. PubMed ID: 26055172
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection.
Kim H; Kim HH; Park JS; Shin HJ; Cha JH; Chae EY; Choi WJ
Br J Radiol; 2014 Nov; 87(1043):20140142. PubMed ID: 25162970
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlations.
Tomida K; Ishida M; Umeda T; Sakai S; Kawai Y; Mori T; Kubota Y; Mekata E; Naka S; Abe H; Okabe H; Tani T
Mol Clin Oncol; 2014 Sep; 2(5):783-788. PubMed ID: 25054046
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging for assessment after neoadjuvant chemotherapy in breast cancer, based on morphological concepts.
Murata Y; Kubota K; Hamada N; Miyatake K; Tadokoro M; Nakatani K; Ue H; Tsuzuki K; Nishioka A; Iguchi M; Maeda H; Ogawa Y
Oncol Lett; 2010 Mar; 1(2):293-298. PubMed ID: 22966297
[TBL] [Abstract][Full Text] [Related]
8. Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer.
Yang X; Mrozek E; Lustberg M; Jia G; Sammet S; Sammet C; Shapiro C; Knopp MV
Magn Reson Imaging; 2012 Oct; 30(8):1059-67. PubMed ID: 22884756
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.
de Bazelaire C; Calmon R; Thomassin I; Brunon C; Hamy AS; Fournier L; Balvay D; Espié M; Siauve N; Clément O; de Kerviler E; Cuénod CA
BMC Cancer; 2011 Aug; 11():361. PubMed ID: 21854572
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy.
Lyou CY; Cho N; Kim SM; Jang M; Park JS; Baek SY; Moon WK
Korean J Radiol; 2011; 12(1):34-43. PubMed ID: 21228938
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.
Shin HJ; Kim HH; Ahn JH; Kim SB; Jung KH; Gong G; Son BH; Ahn SH
Br J Radiol; 2011 Jul; 84(1003):612-20. PubMed ID: 21081579
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy.
Uematsu T; Kasami M; Yuen S
Eur Radiol; 2010 Oct; 20(10):2315-22. PubMed ID: 20455064
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging.
Tozaki M; Oyama Y; Fukuma E
Jpn J Radiol; 2010 Feb; 28(2):101-9. PubMed ID: 20182844
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.
Prati R; Minami CA; Gornbein JA; Debruhl N; Chung D; Chang HR
Cancer; 2009 Mar; 115(6):1194-202. PubMed ID: 19156919
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.
Medarova Z; Rashkovetsky L; Pantazopoulos P; Moore A
Cancer Res; 2009 Feb; 69(3):1182-9. PubMed ID: 19141648
[TBL] [Abstract][Full Text] [Related]
16. Contemporary problems in the surgical management of breast cancer: the surgical/radiological interface.
Beechey-Newman N
Cancer Imaging; 2000 Oct; 1(1):18-24. PubMed ID: 18194883
[No Abstract] [Full Text] [Related]
17. Monitoring therapeutic efficacy in breast carcinomas.
Tardivon AA; Ollivier L; El Khoury C; Thibault F
Eur Radiol; 2006 Nov; 16(11):2549-58. PubMed ID: 16733676
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy of breast carcinomas: what post-therapeutic (preoperative) information is provided by quantitative dynamic MRI?].
Wasser K; Klein SK; Junkermann H; Sinn HP; Darai S; Neff W; Kauczor HU; Delorme S
Radiologe; 2007 May; 47(5):421-9. PubMed ID: 16283153
[TBL] [Abstract][Full Text] [Related]
19. Imaging in evaluation of response to neoadjuvant breast cancer treatment.
Ollivier L; Balu-Maestro C; Leclère J
Cancer Imaging; 2005 May; 5(1):27-31. PubMed ID: 16154816
[TBL] [Abstract][Full Text] [Related]
20. State of the art of current modalities for the diagnosis of breast lesions.
Di Maggio C
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S56-69. PubMed ID: 15085294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
